(opens in a new window)

Marissa B Wilck, MBChB

Adjunct Associate Professor of Medicine (Infectious Diseases)

  • Attending Physician, Hospital of the University of Pennsylvania

Department: Medicine
Division: Infectious Diseases


Contact Information

Merck & Co., Inc.
North Wales, PA 19454


I3H Keywords

  • Innate and Adaptive Immunity to Pathogens

Education

  • MBChB (Medical Doctor)
    Faculty of Health Sciences, University of Cape Town, South Africa , 1996
  • DTM&H (Diploma in Tropical Medicine and Hygiene)
    London School of Tropical Medicine and Hygiene, London, England, 1999
  • Certif (Program in Clinical Effectiveness)
    Harvard Chan School of Public Health, Boston, MA, 2006
  • MS (Masters in Health Sciences and Technology)
    Harvard, MIT Division of Health Sciences and Technology, Beth Israel Deaconess Medical Center, Boston, MA, 2010

Post-Graduate Training

  • Fellow in Clinical Microbiology
    Yale New Haven Hospital, New Haven, CT , 1999 - 2000
  • Intern in Medicine
    Georgetown Program, Washington Hospital Center, Washington, DC , 2000 - 2001
  • Resident in Medicine
    Georgetown Program, Washington Hospital Center, Washington, DC , 2001 - 2003
  • Chief Resident in Medicine
    Georgetown Program, Washington Hospital Center, Washington, DC , 2003 - 2004
  • Clinical and Research Fellow in Infectious Diseases
    Massachusetts General Hospital and Brigham and Women's Hospital, Boston, MA. , 2004 - 2006
  • Clinical Fellow in Medicine
    Harvard Medical School Boston, MA , 2004 - 2005
  • Intern in Medicine
    Groote Schuur Hospital, Cape Town, South Africa , 1997 - 1997

Certifications

  • Board Certified in Infectious Diseases ABIM Recertification 2016, 2016
  • Board Certified in Internal Medicine ABIM, 2004

Selected Publications

  • D.E.Winetsky, J.Myers, S.Schulz, G.Tino, M.Wilck : A Case of Cavitary Pulmonary Mycobacterium Avium Intracellulare Infection in the Setting of Leflunomide Treatment. Letter to the Editor Journal of Clinical Rheumatology 23(4) : 231, June 2017
  • Schneeweiss, Sebastian; Carver, Peggy; Datta, Kausik; Galar, Alicia; Johnson, Melissa; Johnson, Matthew; Marty, Francisco; Nagel, Jerod; Najdzinowicz, Maryann ; Saul, Melissa; Shoham, Shmuel; Silveira, Fernanda ; Varughese, Christine ; Wilck, Marissa; Weatherby, Lisa; Auton, Tim; Walker, Alexander : Short-term Risk of Liver and Renal Injury in Hospitalized Patients Using Micafungin – A Multicenter Cohort Study. Journal of Antimicrobial Chemotherapy 71(10) : 2938-44, Oct 2016
  • Mills JP, Wilck MB, Weikert BC, Porrett PM, Timko D, Alby K, Bonomo RA, Blumberg EA. : Successful treatment of a disseminated infection with extensively drug-resistant Klebsiella pneumoniae in a liver transplant recipient with a fosfomycin-based multidrug regimen. Transpl Infect Dis 18(5) : 777-781, Oct 2016
  • Walsh SR, Moodie Z, Fiore-Gartland AJ, Morgan C, Wilck MB, Hammer SM, Buchbinder SP, Kalams SA, Goepfert PA, Mulligan MJ, Keefer MC, Baden LR, Swann EM, Grant S, Ahmed H, Li F, Hertz T, Self SG, Friedrich D, Frahm N, Liao HX, Haynes BF, Montefiore DC, Tomaras GD, McElrath JM, Hura J, Graham BS, Jin X, HVTN 083 Study Group, NIAID HIV Vaccine Trials Network : Vaccination with heterologous HIV envelope sequences and heterologous adenovirus vectors increases T cell responses to conserved regions (HVTN 083) Journal of Infectious Disease 213(4) : 541-50, Feb 15 2016
  • Wine-Lee L, Keller SC, Wilck MB, Gluckman SJ, Van Voorhees AS : From the Medical Board of the National Psoriasis Foundation: Vaccination in adult patients on systemic therapy for psoriasis Journal of the American Academy of Dermatology 69(6) : 1003-1013, Sep 2013
  • Walsh SR, Wilck MB, Dominguez DJ, Zablowsky E, Bajimaya S, Gagne LS, Verrill KA, Kleinjan JA, Patel A, Zhang Y, Hill H, Acharyya A, Fisher DC, Antin JH, Seaman MS, Dolin R, Baden LR : Safety and immunogenicity of modified vaccinia ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial The Journal of Infectious Diseases 207(12) : 1888-97, June 2013
  • Kharfan-Dabaja MA, Boeckh M, Wilck MB, Langston AA, Chu AH, Wloch MK, Guterwill DF, Smith LR, Rolland AP, Kenney RT : A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial The Lancet Infectious Diseases 12(4) : 290-9, Apr 2012
  • Wilck MB, Seaman MS, Baden LR, Walsh SR, Grandpre LE, Devoy C, Giri A, Kleinjan JA, Noble LC, Stevenson KE, Kim HT, Dolin R. : Safety and Immunogenicity of Modified Vaccinia Ankara (ACAM3000): Effect of Dose and Route of Administration Journal Infectious Diseases 201(9) : 1361-1370, May 1 2010
  • Seaman MS, Wilck MB, Baden LR, Walsh SR, Grandpre LE, Devoy C, Giri A, Noble LC, Kleinjan JA, Stevenson KE, Kim HT, Dolin R : Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with Dryvax Journal of Infectious Diseases 201(9) : 1353-1360, May 2010
  • Wilck MB, Hamel MB, Baden LR : Clinical decisions. Management of incidental hepatitis C virus infection--polling results The New England Journal of Medicine 360(23) : e30, June 2009